Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -19.54% | -14.66% | 5.84% | 18.75% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -19.54% | -14.66% | 5.84% | 18.75% | |
| Cost of Revenue | -20.89% | -17.42% | 5.68% | 19.49% | |
| Gross Profit | -16.51% | -7.39% | 6.18% | 17.12% | |
| SG&A Expenses | -16.06% | 64.59% | 4.96% | 19.32% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -6,257.95% | 1,389.27% | 68.99% | -101.68% | |
| Total Operating Expenses | -20.01% | -13.55% | 5.93% | 18.86% | |
| Operating Income | -10.75% | -35.30% | 4.09% | 16.80% | |
| Income Before Tax | -13.83% | -60.47% | -1.11% | -1.29% | |
| Income Tax Expenses | -57.16% | 129.59% | 150.24% | 41.66% | |
| Earnings from Continuing Operations | 30.53% | -242.21% | -24.18% | -24.66% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 30.53% | -242.21% | -24.18% | -24.66% | |
| EBIT | -10.75% | -35.30% | 4.09% | 16.80% | |
| EBITDA | -8.56% | -55.70% | 11.41% | 11.99% | |
| EPS Basic | 31.33% | -241.98% | -23.81% | -25.23% | |
| Normalized Basic EPS | -6.54% | -55.88% | -1.10% | 0.00% | |
| EPS Diluted | 31.33% | -241.98% | -23.81% | -25.23% | |
| Normalized Diluted EPS | -6.54% | -55.88% | -1.10% | 0.00% | |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |